Cover Image
Market Research Report
Product code 
1083109

Global Throat Cancer Therapeutics Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Throat Cancer Therapeutics Market 2022-2026
Published: May 31, 2022
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Technavio has been monitoring the throat cancer therapeutics market and it is poised to grow by $ 1.82 bn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the throat cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of throat cancer, increasing use of tobacco products, and increasing risk factors.

The throat cancer therapeutics market analysis includes type segment and geographic landscape.

Technavio's throat cancer therapeutics market is segmented as below:

By Type

  • Pharyngeal cancer
  • Laryngeal cancer

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the strategic alliances as one of the prime reasons driving the throat cancer therapeutics market growth during the next few years. Also, patient assistance programs and a strong pipeline will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the throat cancer therapeutics market covers the following areas:

  • Throat cancer therapeutics market sizing
  • Throat cancer therapeutics market forecast
  • Throat cancer therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading throat cancer therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd., Merck KGaA, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, Spectrum Pharmaceuticals Inc., Accord Healthcare Ltd., Athenex Inc., Fresenius SE, and Co. KGaA, Hikma Pharmaceuticals Plc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and WG Critical Care LLC. Also, the throat cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73577

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 Pharyngeal cancer - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
  • 5.4 Laryngeal cancer - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Type
  • Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Hungary - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Hungary - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Hungary - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Hungary - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Hungary - Year-over-year growth 2021-2026 (%)
  • 7.9 India - Market size and forecast 2021-2026
  • Exhibit 66: Chart on India - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on India - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on India - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on India - Year-over-year growth 2021-2026 (%)
  • 7.10 Poland - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Poland - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Poland - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Poland - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Poland - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Amgen Inc.
  • Exhibit 85: Amgen Inc. - Overview
  • Exhibit 86: Amgen Inc. - Product / Service
  • Exhibit 87: Amgen Inc. - Key offerings
  • 10.4 AstraZeneca Plc
  • Exhibit 88: AstraZeneca Plc - Overview
  • Exhibit 89: AstraZeneca Plc - Product / Service
  • Exhibit 90: AstraZeneca Plc - Key news
  • Exhibit 91: AstraZeneca Plc - Key offerings
  • 10.5 Bristol Myers Squibb Co.
  • Exhibit 92: Bristol Myers Squibb Co. - Overview
  • Exhibit 93: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 94: Bristol Myers Squibb Co. - Key offerings
  • 10.6 Celldex Therapeutics Inc.
  • Exhibit 95: Celldex Therapeutics Inc. - Overview
  • Exhibit 96: Celldex Therapeutics Inc. - Product / Service
  • Exhibit 97: Celldex Therapeutics Inc. - Key offerings
  • 10.7 Eli Lilly and Co.
  • Exhibit 98: Eli Lilly and Co. - Overview
  • Exhibit 99: Eli Lilly and Co. - Product / Service
  • Exhibit 100: Eli Lilly and Co. - Key offerings
  • 10.8 F. Hoffmann La Roche Ltd.
  • Exhibit 101: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 102: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 103: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 104: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 105: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.9 Hangzhou Adlai Nortye Biopharma Co. Ltd.
  • Exhibit 106: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
  • Exhibit 107: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product / Service
  • Exhibit 108: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
  • 10.10 Merck KGaA
  • Exhibit 109: Merck KGaA - Overview
  • Exhibit 110: Merck KGaA - Business segments
  • Exhibit 111: Merck KGaA - Key news
  • Exhibit 112: Merck KGaA - Key offerings
  • Exhibit 113: Merck KGaA - Segment focus
  • 10.11 Pfizer Inc.
  • Exhibit 114: Pfizer Inc. - Overview
  • Exhibit 115: Pfizer Inc. - Product / Service
  • Exhibit 116: Pfizer Inc. - Key news
  • Exhibit 117: Pfizer Inc. - Key offerings
  • 10.12 Regeneron Pharmaceuticals Inc.
  • Exhibit 118: Regeneron Pharmaceuticals Inc. - Overview
  • Exhibit 119: Regeneron Pharmaceuticals Inc. - Product / Service
  • Exhibit 120: Regeneron Pharmaceuticals Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 121: Inclusions checklist
  • Exhibit 122: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 123: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 124: Research methodology
  • Exhibit 125: Validation techniques employed for market sizing
  • Exhibit 126: Information sources
  • 11.5 List of abbreviations
  • Exhibit 127: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Type
  • Exhibits27: Data Table on Comparison by Type
  • Exhibits28: Chart on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Pharyngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Pharyngeal cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Laryngeal cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Laryngeal cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Type ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Hungary - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Hungary - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Hungary - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Hungary - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on India - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on India - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on India - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on India - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Poland - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Poland - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Poland - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Poland - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Amgen Inc. - Overview
  • Exhibits86: Amgen Inc. - Product / Service
  • Exhibits87: Amgen Inc. - Key offerings
  • Exhibits88: AstraZeneca Plc - Overview
  • Exhibits89: AstraZeneca Plc - Product / Service
  • Exhibits90: AstraZeneca Plc - Key news
  • Exhibits91: AstraZeneca Plc - Key offerings
  • Exhibits92: Bristol Myers Squibb Co. - Overview
  • Exhibits93: Bristol Myers Squibb Co. - Product / Service
  • Exhibits94: Bristol Myers Squibb Co. - Key offerings
  • Exhibits95: Celldex Therapeutics Inc. - Overview
  • Exhibits96: Celldex Therapeutics Inc. - Product / Service
  • Exhibits97: Celldex Therapeutics Inc. - Key offerings
  • Exhibits98: Eli Lilly and Co. - Overview
  • Exhibits99: Eli Lilly and Co. - Product / Service
  • Exhibits100: Eli Lilly and Co. - Key offerings
  • Exhibits101: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits102: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits103: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits104: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits105: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits106: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
  • Exhibits107: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product / Service
  • Exhibits108: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
  • Exhibits109: Merck KGaA - Overview
  • Exhibits110: Merck KGaA - Business segments
  • Exhibits111: Merck KGaA - Key news
  • Exhibits112: Merck KGaA - Key offerings
  • Exhibits113: Merck KGaA - Segment focus
  • Exhibits114: Pfizer Inc. - Overview
  • Exhibits115: Pfizer Inc. - Product / Service
  • Exhibits116: Pfizer Inc. - Key news
  • Exhibits117: Pfizer Inc. - Key offerings
  • Exhibits118: Regeneron Pharmaceuticals Inc. - Overview
  • Exhibits119: Regeneron Pharmaceuticals Inc. - Product / Service
  • Exhibits120: Regeneron Pharmaceuticals Inc. - Key offerings
  • Exhibits121: Inclusions checklist
  • Exhibits122: Exclusions checklist
  • Exhibits123: Currency conversion rates for US$
  • Exhibits124: Research methodology
  • Exhibits125: Validation techniques employed for market sizing
  • Exhibits126: Information sources
  • Exhibits127: List of abbreviations